The Internal Revenue Service is reminding taxpayers that the cost of home testing for COVID-19 is eligible as an eligible medical expense that can be paid or reimbursed under health flexible spending arrangements such as health FSAs, HSAs, HRAs, and Archer MSAs. That is because the cost to diagnose COVID-19 is an eligible medical expense for tax purposes.